The GLP-1 Receptor Agonist Exenatide Ameliorates Bone Composition and Tissue Material Properties in High Fat Fed Diabetic Mice

The GLP-1 Receptor Agonist Exenatide Ameliorates Bone Composition and Tissue Material Properties in High Fat Fed Diabetic Mice

Type 2 diabetes mellitus (T2DM) has recently been recognized as a significant risk factor for bone fragility. Careful investigations of bone mechanical properties in human studies suggested possible alterations of bone composition, although this axis has poorly been investigated. The main aim of thi...

Full description

Bibliographic Details
Main Authors: Sity Aishah Mansur, Aleksandra Mieczkowska, Peter R. Flatt, Daniel Chappard, Nigel Irwin, Guillaume Mabilleau
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-02-01
Series:Frontiers in Endocrinology
Subjects:
exenatide
bone fragility
bone composition
type 2 diabetes
glucagon-like peptide-1
Online Access:https://www.frontiersin.org/article/10.3389/fendo.2019.00051/full

Internet

https://www.frontiersin.org/article/10.3389/fendo.2019.00051/full

Similar Items